De BroeM. (1973). Symposium international rein et furosemide, p. 47. France: Valescure.
2.
DolleryC. T. (1973). Editorial. European Journal of Clinical Pharmacology, 6, 1.
3.
RuppW.HeidlandA.HajduP.NeuhausG. (1970). In Medikamentöse Therapie bei Nierenerkrankungen 4 Freiburger Tag. üb. Fortschritte d. Nephrologie, p. 207. Stuttgart: Thieme Verlag.
RuppW.ZapfR. M. (1973). Arzneimittel-Forschung (Drug Res.), 23, 1665.
6.
RuppW.HajduP. (1970). In Pharmacological and Clinical Significance of Pharmacokinetics, ed. DenglerH. J., p. 105. Stuttgart: Schattauer Verlag.
7.
AllisonM. E. M.KennedyA. C. (1971). Diuretics in chronic renal disease: a study of high dosage frusemide. Clinical Science, 41, 171.
8.
WigandM. E.HeidlandA. (1971). Ototoxic side effects of high doses of frusemide in patients with uraemia. Postgraduate Medical Journal, April Suppl., 54.
9.
WigandM. E. (1972). Cochlear-vestibular disorders in uraemia with reference to electrolyte metabolism and glomerular filtration. (In German.)Schweizerische medizinische Wochenschrift, 102, 477.